Literature DB >> 28131622

Perinatal nicotine treatment induces transient increases in NACHO protein levels in the rat frontal cortex.

Franziska Wichern1, Majbrit M Jensen2, Ditte Z Christensen2, Jens D Mikkelsen2, Marjorie C Gondré-Lewis3, Morten S Thomsen4.   

Abstract

The nicotinic acetylcholine receptor (nAChR) regulator chaperone (NACHO) was recently identified as an important regulator of nAChR maturation and surface expression. Here we show that NACHO levels decrease during early postnatal development in rats. This decrease occurs earlier and to a greater degree in the frontal cortex (FC) compared with the hippocampus (HIP). We further show that rats exposed to nicotine during pre- and postnatal development exhibit significantly higher NACHO levels in the FC at postnatal day (PND) 21, but not at PND60. Repeated exposure to nicotine selectively during early (PND8-14) or late (PND54-60) postnatal stages did not affect NACHO protein levels in the FC or HIP, neither did exposure to high doses of the selective α7 nAChR agonists SSR180711, A-582941, or PNU-282987. However, we found significantly increased NACHO protein levels in the FC of PND36 rats after a single exposure to a combination of nicotine and the type II α7 nAChR positive allosteric modulator (PAM) PNU-120596, but not the type I PAM AVL-3288. These findings suggest that exposure to nAChR agonism affects NACHO protein levels, and that this effect is more pronounced during pre- or early postnatal development. The effect of PNU-120596 further suggests that the increase in NACHO expression is caused by activation rather than desensitization of nAChRs.
Copyright © 2017 IBRO. All rights reserved.

Entities:  

Keywords:  TMEM35; allosteric modulator; chaperone; development; nicotinic acetylcholine receptor; nicotinic acetylcholine receptor regulator

Mesh:

Substances:

Year:  2017        PMID: 28131622      PMCID: PMC5360531          DOI: 10.1016/j.neuroscience.2017.01.026

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.

Authors:  Raymond S Hurst; Mihaly Hajós; Mario Raggenbass; Theron M Wall; Nicole R Higdon; Judy A Lawson; Karen L Rutherford-Root; Mitchell B Berkenpas; W E Hoffmann; David W Piotrowski; Vincent E Groppi; Geraldine Allaman; Roch Ogier; Sonia Bertrand; Daniel Bertrand; Stephen P Arneric
Journal:  J Neurosci       Date:  2005-04-27       Impact factor: 6.167

2.  Expression of the Ly-6 family proteins Lynx1 and Ly6H in the rat brain is compartmentalized, cell-type specific, and developmentally regulated.

Authors:  Morten Skøtt Thomsen; Betül Cinar; Majbrit Myrup Jensen; Ekaterina N Lyukmanova; Mikhail A Shulepko; Victor Tsetlin; Anders Bue Klein; Jens D Mikkelsen
Journal:  Brain Struct Funct       Date:  2013-07-17       Impact factor: 3.270

Review 3.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

4.  Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of α7 nicotinic acetylcholine receptors.

Authors:  Morten S Thomsen; Jens D Mikkelsen
Journal:  J Neurochem       Date:  2012-08-16       Impact factor: 5.372

Review 5.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

6.  Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain.

Authors:  X Zhang; C Liu; H Miao; Z H Gong; A Nordberg
Journal:  Int J Dev Neurosci       Date:  1998-10       Impact factor: 2.457

7.  Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.

Authors:  Robert S Bitner; William H Bunnelle; David J Anderson; Clark A Briggs; Jerry Buccafusco; Peter Curzon; Michael W Decker; Jennifer M Frost; Jens Halvard Gronlien; Earl Gubbins; Jinhe Li; John Malysz; Stella Markosyan; Kennan Marsh; Michael D Meyer; Arthur L Nikkel; Richard J Radek; Holly M Robb; Daniel Timmermann; James P Sullivan; Murali Gopalakrishnan
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

Review 8.  Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer's Disease: The Role of Protein-Protein Interactions in Current and Future Treatment.

Authors:  Morten Skøtt Thomsen; Jesper Tobias Andreasen; Maria Arvaniti; Kristi Anne Kohlmeier
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 9.  Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.

Authors:  Anitha P Govind; Paul Vezina; William N Green
Journal:  Biochem Pharmacol       Date:  2009-06-18       Impact factor: 5.858

10.  Functional interaction between Lypd6 and nicotinic acetylcholine receptors.

Authors:  Maria Arvaniti; Majbrit M Jensen; Neeraj Soni; Hong Wang; Anders B Klein; Nathalie Thiriet; Lars H Pinborg; Pretal P Muldoon; Jacob Wienecke; M Imad Damaj; Kristi A Kohlmeier; Marjorie C Gondré-Lewis; Jens D Mikkelsen; Morten S Thomsen
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

View more
  2 in total

Review 1.  Mitochondria as a possible target for nicotine action.

Authors:  Dominika Malińska; Mariusz R Więckowski; Bernadeta Michalska; Karolina Drabik; Monika Prill; Paulina Patalas-Krawczyk; Jarosław Walczak; Jędrzej Szymański; Carole Mathis; Marco Van der Toorn; Karsta Luettich; Julia Hoeng; Manuel C Peitsch; Jerzy Duszyński; Joanna Szczepanowska
Journal:  J Bioenerg Biomembr       Date:  2019-06-13       Impact factor: 2.945

2.  NACHO and 14-3-3 promote expression of distinct subunit stoichiometries of the α4β2 acetylcholine receptor.

Authors:  Simone Mazzaferro; Sara T Whiteman; Constanza Alcaino; Arthur Beyder; Steven M Sine
Journal:  Cell Mol Life Sci       Date:  2020-07-16       Impact factor: 9.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.